Cue BioPharma
CUE----
Forecast & Rating3 analysts currently cover Cue BioPharma, of which 3 give a positive rating. The average price target is $88.00, about 364.4% upside from the current price of $18.95. Coverage is limited, so the data is for reference only. Data as of Oct 1, 2026; this does not constitute investment advice.
Oct 1, 2026Price forecast
$88.00364.38%
Forecast & RatingStrong buy
3analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateOct 19, 2026
Forecast met0.0%
Stock price$18.95
Avg. target$88.0
High target$115
Low target$66
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.